Education
About Us
Working with TipRanks
Follow Us
Paul I. Moskowitz Insider Profile
4 Followers
Paul I. Moskowitz, Director at Sonnet BioTherapeutics Holdings, holds 18.10K shares in Sonnet BioTherapeutics Holdings (Ticker: SONN).
Paul I. Moskowitz Sonnet BioTherapeutics Holdings (SONN)Director
Sonnet BioTherapeutics Holdings (SONN)
Director
Not Ranked
Paul I. Moskowitz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Paul I. Moskowitz does not currently own shares as a corporate insider.
A breakdown of Paul I. Moskowitz's holdings
Insider Roles
Paul I. Moskowitz does not currently hold a role as a corporate insider.
Roles that Paul I. Moskowitz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Paul I. Moskowitz
Paul I. Moskowitz's Trading History
List of latest transactions for each holding click on a transaction to see Paul I. Moskowitz's performance on stock
You May Also Like
Paul I. Moskowitz insider profile FAQ
What is the percentage of profitable transactions made by Paul I. Moskowitz?
The percentage of profitable transactions made by Paul I. Moskowitz is ―.
What is the average return per transaction made by Paul I. Moskowitz?
The average return per transaction made by Paul I. Moskowitz is ―.
What stocks does Paul I. Moskowitz hold?
Paul I. Moskowitz holds: SONN stocks.
What was Paul I. Moskowitz’s latest transaction?
Paul I. Moskowitz latest transaction was an Uninformative Buy of $40.05K.
What was Paul I. Moskowitz's most profitable transaction?
Paul I. Moskowitz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Paul I. Moskowitz's role in Sonnet BioTherapeutics Holdings?
Paul I. Moskowitz's role in Sonnet BioTherapeutics Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.